This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Memorial Hospital for Cancer and Allied Diseases, Memorial Sloan Kettering Cancer Center, Millennium Pharmaceuticals Limited. Active years: 2026.
Company Filing History:
1 out of 25 
1 out of 618 
1 out of 854 
Years Active: 2026
Title: Mei Rosa Ng: Innovator in Chimeric Antigen Receptors
Introduction
Mei Rosa Ng is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of immunology, particularly in the development of chimeric antigen receptors.
Latest Patents
Ng holds a patent for "Chimeric Antigen Receptors Targeting CD19 and Use Thereof." This innovative work focuses on enhancing the effectiveness of targeted therapies in treating certain types of cancers.
Career Highlights
Throughout her career, Mei Rosa Ng has worked with notable organizations, including Millennium Pharmaceuticals Limited and Memorial Hospital for Cancer and Allied Diseases. Her experience in these institutions has allowed her to advance her research and contribute to groundbreaking developments in cancer treatment.
Collaborations
Ng has collaborated with esteemed colleagues such as Judith Feucht and Jorge Mansilla-Soto. These partnerships have fostered a collaborative environment that promotes innovation and research excellence.
Conclusion
Mei Rosa Ng's work in developing chimeric antigen receptors represents a significant advancement in cancer therapy. Her contributions continue to impact the field positively, showcasing her dedication to improving patient outcomes.